Franmedsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-02-09
Share capital
100,000.00 PLN
Registered address
ul. Kamionkowska 19/U1, 03-805 Warszawa, Poland
Electronic delivery address
AE:PL-99801-51215-GBTVG-23

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 87 days late).

  • 202508/07/2026
  • 202414/07/2025
  • 202325/06/2024
  • 202213/07/2023
  • 202110/10/2022
  • 202029/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.16mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 70.77kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 1.08mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 599.86kMedianUSD 544.32kAverageUSD 1.76m

Authorized Representatives

Wojciech Marek Kania – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Lenka Kaniaage 48
1,000$13,506.2150%
Wojciech Marek Kaniaage 51
1,000$13,506.2150%

Lenka Kania and Wojciech Marek Kania hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2017-02-21.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 6,004

Public aid

5 public aid cases recorded, with a total value of $23,108.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,128
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,134

Competitors

Name
Cosmedicasp. z o.o.
DR ZdrowieS.A.
MagmaxS.A.
Novopharm - Millersp. j.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Nukloversp. z o.o.
Massmedsp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.
Femaherbsp. z o.o.

FAQ

Last updated: 2026-07-15